Biotechnology This is an OPML file. It can be used to export all the MedWorm RSS feeds on this topic into your personal RSS reader (usually you have to save this file to your own computer before clicking on an Import OPML command in your own feed reader to upload the file which will then import all the feeds) or it can be used by webmasters to integrate MedWorm feeds with their own website. This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader, such as GoogleReader, or to display this data on your own website or blog. Subscribe to this data using MyMedWorm.Subscribe to this data using GoogleReader.Subscribe to this data using Bloglines.Subscribe to this data using MyYahoo.
Find the best Christmas presents and January Sales in the UK with this simple shopping directory.
This page shows you the most recent publications within this specialty of the MedWorm directory. This is page number 17.
Tengion applies for clinical trial in Sweden
Tengion has submitted an application to begin a Phase 1 clinical trial of its Neo-Kidney Augment product in Sweden, the company said in a news release. Tengion (OTC: TNGN) is the Winston-Salem company that is working to commercialize some of the technologies developed by Dr. Anthony Atala at the Wake Forest Institute for Regenerative Medicine. The company hopes the Neo-Kidney Augment will prove an effective method of regenerating healthy kidney tissue in patients with advanced chronic kidney disease. The…
Source: bizjournals.com Health Care:Biotechnology headlines - January 30, 2013 Category: Biotechnology Authors: Matt Evans Source Type: research
Report: Mayor Ed Lee says CPMC-Cathedral Hill compromise is 'imminent'
A "compromise agreement is imminent" that would allow California Pacific Medical Center to move forward on its $2.5 billion plans to rebuild St. Luke's Hospital and build a new, albeit smaller than planned, hospital on Cathedral Hill, the San Francisco Examiner reported Tuesday. Mayor Ed Lee said Tuesday that the San Francisco Board of Supervisors had postponed its latest planned vote on the project until March 12, the Examiner reported late Tuesday. But "this is the last extension," Lee predicted,…
Source: bizjournals.com Health Care:Biotechnology headlines - January 30, 2013 Category: Biotechnology Authors: Chris Rauber Source Type: research
American Heart Association kicks off Heart Walk campaign
The American Heart Association in Birmingham today kicked off the campaign that will culminate into the annual Heart Walk on June 22. AHA officials said they have a $550,000 fundraising goal for this year's Heart Walk, and the organization hosted an executive breakfast at the downtown Sheraton this morning to announce the initiative. William Stevens, president and CEO of Motion Industries in Birmingham, addressed local business officials during the breakfast and called on them to assist with the…
Source: bizjournals.com Health Care:Biotechnology headlines - January 30, 2013 Category: Biotechnology Authors: Yann Ranaivo Source Type: research
RNA Fragments May Yield Rapid, Accurate Cancer Diagnosis
Fragments of RNA that cells eject in fatty droplets may point the way to a new era of cancer diagnosis, potentially eliminating the need for invasive tests in certain cases. [More]
Source: Scientific American - Official RSS Feed - January 30, 2013 Category: Science Tags: Health,Health,Mind & Brain,Technology,Medical Technology,Neurological Disorders,Neuroscience,Biotechnology,Biotechnology,Biology,More Science Source Type: research
Biotech propaganda exposed as GM risks grow
Distorted EuropaBio report published on same day as news of viral fragments in GM
Source: Alliance for Natural Health - January 30, 2013 Category: Complementary Medicine Authors: Sophie Tags: Anne Glover EuopaBio europe gene gentically modified GM international potentially dangerous viral fragments Source Type: news
Biotech M&A in 2012: The Good, Bad, and Ugly
The numbers are in on the 2012 Pharma/Biotech M&A performance, at least according to our friends at HBM Partners. They’ve released another well-annotated deal report and database.
Source: Forbes.com Healthcare News - January 30, 2013 Category: Pharmaceuticals Authors: Bruce Booth Source Type: news
American CryoStem (OTCQB:CRYO) Announces Partnership With Orlando Florida Medical Rejuvenation Center (Eterna M.D.) to Offer ATGRAFT(TM) Fat Storage Service for Natural Cosmetic Enhancements to Their Patients
EATONTOWN, N.J., Jan. 30, 2013 (GLOBE NEWSWIRE) -- American CryoStem Corporation (OTCQB:CRYO), a leading biotech company in the field of Regenerative Medicine, is proud to announce that
Source: Medical News (via PRIMEZONE) - January 30, 2013 Category: Pharmaceuticals Source Type: news
Healthcare Sales Jobs Rising Despite Challenges Facing the Industry
Report from MedReps.com suggests most medical device, pharmaceutical, and biotech companies continue with sales hiring.(PRWeb January 30, 2013)Read the full story at http://www.prweb.com/releases/medicalsalesjobs/janreport/prweb10372833.htm
Source: PRWeb: Medical Pharmaceuticals - January 30, 2013 Category: Pharmaceuticals Source Type: news
Savaria Corporation: Savaria Corporation Launches a Normal Course Issuer Bid
LAVAL, QUEBEC (MARKET WIRE) Savaria Corporation ("Savaria") (TSX: SIS), North America's leader in the accessibility industry, today announced that it has received Toronto Stock Exchange ("TSX") approval to a Notice of Intention to implement a normal course issuer bid. According to the notice, Savaria intends to purchase for cancellation, in accordance with the requirements of the TSX, up to 1,155,000 common shares, representing less than 5 % of the 23,142,064 common shares that are issued and outstanding as of January 16, 2013.
Source: Market Wire - Pharmaceuticals and Biotech - January 30, 2013 Category: Pharmaceuticals Tags: Pharmaceuticals and Biotech Medical and Healthcare SIS Source Type: news
Novo Nordisk A/S: Novo Nordisk A/S - Share repurchase programme
BAGSVAERD, DENMARK (MARKET WIRE) On 9 November 2012 Novo Nordisk initiated a share repurchase programme in accordance with the provisions of the European Commission's regulation no 2273/2003 of 22 December 2003, also referred to as the Safe Harbour rules.
Source: Market Wire - Pharmaceuticals and Biotech - January 30, 2013 Category: Pharmaceuticals Tags: Pharmaceuticals and Biotech NOVO Source Type: news
Overview: Nanoscale Science and Engineering for Agriculture and Food Systems
Industrial Biotechnology , Vol. 0, No. 0.
Source: Industrial Biotechnology - January 30, 2013 Category: Biotechnology Tags: article Source Type: research
Ritter Pharmaceuticals: Survey: 75% of People With Lactose Intolerance Avoid Dairy Foods
LOS ANGELES, CA (MARKET WIRE) A recent survey of patients with Lactose Intolerance revealed that more than three fourths of them reduce or eliminate dairy from their diets as the primary means of "managing" their symptoms. What's more, a majority (56%) of them worry about the long-term risks to their health due to this dietary restriction.
Source: Market Wire - Pharmaceuticals and Biotech - January 30, 2013 Category: Pharmaceuticals Tags: Pharmaceuticals and Biotech Medical and Healthcare Source Type: news
SpectraScience, Inc.: SpectraScience and PENTAX Showcase WaveSTAT4 Optical Biopsy System at Arab Health 2013
DUBAI, UNITED ARAB EMIRATES (MARKET WIRE) SpectraScience, Inc. (OTCQB: SCIE), a San Diego based medical device company, today announced that in continuation of its distribution and sales efforts in Europe and the Middle East it is demonstrating its WavSTAT4 Optical Biopsy System at the 38th Annual Arab Health 2013 Exhibition and Congress. The Exhibition is taking place January 28th through 31st, 2013 in Dubai, United Arab Emirates. The WavSTAT4 Optical Biopsy System is available for demonstration at the PENTAX Europe booth at the Exhibition.
Source: Market Wire - Pharmaceuticals and Biotech - January 30, 2013 Category: Pharmaceuticals Tags: Financial Services Pharmaceuticals and Biotech Medical and Healthcare SCIE Source Type: news
Isolation of melanoma tumor-initiating cells from surgical tissues.
Abstract A new model of cancer progression has been put forward that predicts existence of tumor stem cells (TSCs) in the heterogeneous bulk tumor mass that self-renew, are resistant to chemo- and radiotherapies, and sustain tumor growth during the course of its progression or relapse (Ailles and Weissman, Curr Opin Biotechnol 18:460-466, 2007; Chan et al., Proc Natl Acad Sci U S A 106:14016-14021, 2009; D'Angelo and Wicha, Prog Mol Biol Transl Sci 95:113-158, 2010; O'Brien, Semin Radiat Oncol 19:71-77, 2009; Park et al., Mol Ther 17:219-230, 2009). Using most advanced methods of cell purification and transplantati...
Source: Cell Research - January 30, 2013 Category: Cytology Authors: Boiko AD Tags: Methods Mol Biol Source Type: research
Uptake and intracellular distribution of collagen-functionalized single-walled carbon nanotubes.
In this study, single-walled carbon nanotubes (SWCNTs) were functionalized with collagen (collagen-SWCNTs). The collagen-SWCNTs retained the inherent properties of SWCNTs and the suspension solution was stable for months. The cellular effects, uptake and intracellular distribution of the collagen-SWCNTs were investigated by using them for culture of bovine articular chondrocytes (BACs). The collagen-SWCNTs showed no obvious negative cellular effects and high amount of SWCNTs were internalized by cells. The internalized collagen-SWCNTs were distributed in the perinuclear region and retained in the cells for more than one we...
Source: Biomaterials - January 30, 2013 Category: Materials Science Authors: Mao H, Kawazoe N, Chen G Tags: Biomaterials Source Type: research
Biotech Firms in Race for Manufacturing Breakthrough
Two leading biotechnology companies are competing to be the first to implement cheaper, faster processes for producing drugs inside living cells, making it easier to manufacture human proteins, antibodies, and other medications.
Source: PharmaManufacturing.com - January 30, 2013 Category: Pharmaceuticals Authors: Pharma Manufacturing Source Type: news
Induction of laccase activity in the white rot fungus Pleurotus ostreatus using water polluted with wheat straw extracts.
Abstract The purpose of this work was to explore the use of polluted water effluents from wheat straw using industries as inducers of lignocellulolytic enzymatic activities in cultures of white rot basidiomycetes. For this purpose, we studied the effect of a wheat straw water extract on the evolution of the laccase activity recovered from submerged cultures of Pleurotus ostreatus made in different media and under various culture conditions. Our results demonstrated an accumulative induction effect in all the cultures and conditions tested. This induction is parallel to changes in the laccase electrophoretic profile...
Source: Bioresource Technology - January 30, 2013 Category: Biotechnology Authors: Parenti A, Muguerza E, Redin Iroz A, Omarini A, Conde E, Alfaro M, Castanera R, Santoyo F, Ramírez L, Pisabarro AG Tags: Bioresour Technol Source Type: research
Valorization of glycerol through the production of biopolymers: The PHB case using Bacillus megaterium.
Abstract In this work technical and economic analyses were performed to evaluate the glycerol transformation into Polyhydroxybutyrate using Bacillus megaterium. The production of PHB was compared using glycerol or glucose as substrates and similar yields were obtained. The total production costs for PHB generation with both substrates were estimated at an industrial scale. Compared to glucose, glycerol showed a 10% and 20% decrease in the PHB production costs using two different separation schemes respectively. Moreover, a 20% profit margin in the PHB sales price using glycerol as substrate resulted in a 166% valor...
Source: Bioresource Technology - January 30, 2013 Category: Biotechnology Authors: Naranjo JM, Posada JA, Higuita JC, Cardona CA Tags: Bioresour Technol Source Type: research
Modeling for proximate analysis and heating value of torrefied biomass with vibration spectroscopy.
Abstract The goal of this study was to characterize the changes in biomass with torrefaction for near infrared reflectance (NIR) and attenuated total reflectance Fourier transform infrared (ATR-FTIR) spectroscopy for sweetgum, loblolly pine, and switchgrass. Calibration models were built for the prediction of proximate analysis after torrefaction. Two dimensional (2D) correlation spectroscopy between NIR and FTIR was found to precisely explain the depolymerization at key functional groups located within hemicellulose, cellulose, and lignin. This novel 2D technique also demonstrated the possibility of assigning key ...
Source: Bioresource Technology - January 30, 2013 Category: Biotechnology Authors: Via BK, Adhikari S, Taylor S Tags: Bioresour Technol Source Type: research
Genes and Civil Liberties
Conclusion Although human genetics research and development are usually presented as “advances,” they may also be setting back our civil liberties on many fronts. Chief among the downsides are increased numbers of widely-available databases that correlate many facets of people’s biology, lives, and activities, as well as increasing incidences of loss of privacy and discrimination. While federal legislation and administrative rules have begun to address these problems, private and governmental data mining grows rapidly as new technological formats are developed and a technological rationality (i.e., ̶...
Source: ActionBioscience - January 30, 2013 Category: Biology Authors: Ali Hochberg Source Type: news
Controlling the feed rate of glucose and propanol for the enhancement of erythromycin production and exploration of propanol metabolism fate by quantitative metabolic flux analysis.
Abstract In this paper, several different fermentation experiments were designed to address whether modulating glucose and propanol feeds could benefit the production level of erythromycin during pilot plant (30 L) fermentation. Results showed that glucose feed rate (determined by a set high or low culture pH) had no effect on erythromycin production, indicating that glucose was not the limiting factor for erythromycin biosynthesis under these conditions. It was found that decreasing glucose feed could stimulate the consumption of propanol, and the high erythromycin production (12.49 ± 0.50 mg ml(-1)) was ach...
Source: Bioprocess and Biosystems Engineering - January 30, 2013 Category: Biomedical Engineering Authors: Chen Y, Huang M, Wang Z, Chu J, Zhuang Y, Zhang S Tags: Bioprocess Biosyst Eng Source Type: research
BIOCOMPUTATION: some history and prospects.
Abstract At first glance, Biology and Computer Science are diametrically opposed sciences. Biology deals with carbon based life forms shaped by evolution and natural selection. Computer Science deals with electronic machines designed by engineers and guided by mathematical algorithms. In this brief paper, we review biologically inspired computing. We discuss several models of computation which have arisen from various biological studies We show what these have in common, and conjecture how biology can still suggest answers and models for the next generation of computing problems. We discuss computation and argue th...
Source: Biosystems - January 30, 2013 Category: Biotechnology Authors: Cull P Tags: Biosystems Source Type: research
Oligodeoxyribonucleotides derived from salmon sperm DNA: An alternative to defibrotide.
In this study, oligodeoxyribonucleotides were successfully obtained from the controlled depolymerization of salmon sperm DNA. The obtained product shared similar chemical and biological properties with defibrotide produced by Gentium SpA, Italy. It was also found that oligodeoxyribonucleotides derived from non-mammalian origins could also directly stimulate tissue plasminogen activator (t-PA) release from cultured human endothelial cells, and enhance fibrinolytic activity in the rabbit. PMID: 23375586 [PubMed - as supplied by publisher]
Source: Biologicals : Journal of the International Association of Biological Standardization - January 30, 2013 Category: Biotechnology Authors: Hui CY, Guo Y, Zhang X, Shao JH, Yang XQ, Zhang W Tags: Biologicals Source Type: research
Advances in the diagnosis of key gastrointestinal nematode infections of livestock, with an emphasis on small ruminants.
Abstract Parasitic nematodes (roundworms) of livestock have major economic impact globally. In spite of the diseases caused by these nematodes and some advances in the design of new therapeutic agents (anthelmintics) and attempts to develop vaccines against some of them, there has been limited progress in the establishment of practical diagnostic techniques. The specific and sensitive diagnosis of gastrointestinal nematode infections of livestock underpins effective disease control, which is highly relevant now that anthelmintic resistance (AR) is a major problem. Traditional diagnostic techniques have major constr...
Source: Biotechnology Advances - January 30, 2013 Category: Biotechnology Authors: Roeber F, Jex AR, Gasser RB Tags: Biotechnol Adv Source Type: research
Invoking ideology in the promotion of ecological risk assessment for GM crops.
PMID: 23375944 [PubMed - as supplied by publisher]
Source: Trends in Biotechnology - January 30, 2013 Category: Biotechnology Authors: Herman RA, Raybould A Tags: Trends Biotechnol Source Type: research
Plant genetic engineering and agricultural biotechnology 1983-2013.
PMID: 23375945 [PubMed - as supplied by publisher]
Source: Trends in Biotechnology - January 30, 2013 Category: Biotechnology Authors: Christou P Tags: Trends Biotechnol Source Type: research
An integrated high-throughput strategy for rapid screening of poly(γ-glutamic acid)-producing bacteria.
Abstract Poly(γ-glutamic acid) (γ-PGA) is a promising biomaterial with a wide range of unique applications. To extensively screen γ-PGA-producing bacteria with high yield and different molecular weight, we developed an integrated high-throughput strategy. Firstly, γ-PGA-producing bacteria were selected in a primary screen plate containing a basic dye (neutral red) based on the concentric zone formed through the electrostatic interaction between the dye and the secreted acidic polymer γ-PGA. Then, the isolates were cultured in 50 ml tubes instead of 250 ml flasks. A good correlation of fermentation results in...
Source: Applied Microbiology and Biotechnology - January 30, 2013 Category: Microbiology Authors: Zeng W, Lin Y, Qi Z, He Y, Wang D, Chen G, Liang Z Tags: Appl Microbiol Biotechnol Source Type: research
Reduction of volatile acidity of acidic wines by immobilized Saccharomyces cerevisiae cells.
In this study, we aimed to optimize the immobilization of S26 cells in alginate beads for the bioreduction of volatile acidity of acidic wines. We found that S26 cells immobilized in double-layer alginate-chitosan beads could reduce the volatile acidity of an acidic wine (1.1 g L(-1) acetic acid, 12.5 % (v/v) ethanol, pH 3.12) by 28 and 62 % within 72 and 168 h, respectively, associated with a slight decrease in ethanol concentration (0.7 %). Similar volatile acidity removal efficiencies were obtained in medium with high glucose concentration (20 % w/v), indicating that this process may also be useful in the deaci...
Source: Applied Microbiology and Biotechnology - January 30, 2013 Category: Microbiology Authors: Vilela A, Schuller D, Mendes-Faia A, Côrte-Real M Tags: Appl Microbiol Biotechnol Source Type: research
Role of the cmcH-ccaR intergenic region and ccaR overexpression in cephamycin C biosynthesis in Streptomyces clavuligerus.
Abstract The effect of the CcaR regulatory protein on expression of the cephamycin C gene cluster is studied. Quantitative reverse transcription PCR (qRT-PCR) expression analysis of the cephamycin biosynthesis genes in the ccaR-disrupted strain, S. clavuligerus ccaR::aph, revealed that in the absence of CcaR, the lat and cmcI genes expression was reduced 2,200- and 1,087-fold compared with the wild type. Expression of pcbAB-pcbC-cefD-cefE-cmcJ-cmcH and blp was 225- to 359-fold lower, while expression of pcbR-pbpA-bla and orf10 was only slightly affected if at all, indicating that resistance and regulatory genes are...
Source: Applied Microbiology and Biotechnology - January 30, 2013 Category: Microbiology Authors: Kurt A, Alvarez-Álvarez R, Liras P, Ozcengiz G Tags: Appl Microbiol Biotechnol Source Type: research
Comparative analysis of two members of the metal ion-containing group III-alcohol dehydrogenases from Dickeya zeae.
Abstract PURPOSE OF WORK: A pair of NAD(+)- and NADP(+)-dependent group III-alcohol dehydrogenases was characterized from the enterobacterium, Dickeya zeae, to expand our understanding of the distribution and biochemical properties of this interesting group of enzymes. Two putative group III-alcohol dehydrogenases (ADHs) were identified in the genome of Dickeya zeae. Amino acid alignments and phylogenetic analysis revealed that Adh3.1 and Adh3.2 are only distantly related (~25 % identity at the protein level). Both proteins were purified to homogeneity after heterologous expression in E. coli. A spec...
Source: Biotechnology Letters - January 30, 2013 Category: Biotechnology Authors: Elleuche S, Klippel B, von der Heyde A, Antranikian G Tags: Biotechnol Lett Source Type: research
Flocculation Optimization of Microalga Nannochloropsis oculata.
The objective of this work was to understand and optimize the flocculation of a marine alga Nannochloropsis oculata with two cationic salts, aluminum sulfate (AS), and ferric chloride (FC). Based on single-factor and response-surface-methodology experiments, second-order polynomial models were developed to examine the effect of initial algal biomass concentration (IABC), pH, and flocculant dose (FD) on final solid concentration of algae (SCA). The experimental and modeling results showed that SCA favored low pH, which however was undesirable to biomass recovery rate. There existed a positive stoichiometric relationship bet...
Source: Applied Biochemistry and Biotechnology - January 30, 2013 Category: Biochemistry Authors: Shen Y, Cui Y, Yuan W Tags: Appl Biochem Biotechnol Source Type: research
Containing Infectious Diseases with DNA Sequencing
DNA sequencing is finally reaching the point where it is fast and cheap enough to make a real impact on routine healthcare. While most of the interest focuses on its potential to personalize medical treatment based on an individual's genetics, the technology offers much broader potential. For example, automated high throughput DNA sequencing techniques appear to be about to revolutionize our ability to track and contain infectious disease outbreaks....Read Full Post
Source: About.com Biotech Biomedical - January 30, 2013 Category: Biotechnology Source Type: news
Genes and Civil Liberties
Conclusion Although human genetics research and development are usually presented as “advances,” they may also be setting back our civil liberties on many fronts. Chief among the downsides are increased numbers of widely-available databases that correlate many facets of people’s biology, lives, and activities, as well as increasing incidences of loss of privacy and discrimination. While federal legislation and administrative rules have begun to address these problems, private and governmental data mining grows rapidly as new technological formats are developed and a technological rationality (i.e., “...
Source: ActionBioscience - January 30, 2013 Category: Biology Authors: Ali Hochberg Source Type: news
Biotechniques: Cell squeezer gets molecules in
Nature 493, 7434 (2013). doi:10.1038/493581e The cell membrane, largely impermeable to large molecules, can be breached with needles, electricity and chemicals. But now researchers have devised a less traumatic and more efficient way of delivering molecules into cells, involving squeezing cells in a microfluidic device (pictured).A team
Source: Nature - January 30, 2013 Category: Research Tags: Research Highlights Source Type: research
3, 4-dihydroxy-L-phenylalanine-derived melanin from Yarrowia lipolytica mediates the synthesis of silver and gold nanostructures
Conclusion: The yeast mediated enhanced production of the metal-ion-reducing pigment, melanin. A simple and rapid method for the extracellular synthesis of nanoparticles with paint-additive-application was developed.
Source: Journal of Nanobiotechnology - January 30, 2013 Category: Nanotechnology Authors: Mugdha ApteGauri GirmeAshok BankarAmeeta RaviKumarSmita Zinjarde Source Type: research
Prevalence and relationship of human papilloma virus type 16 and type 18 with oral squamous cell carcinoma and oral leukoplakia in fresh scrappings: A PCR study
Conclusions:HPV type 16, 18, and co-infection of both types showed high prevalence in oral squamous cell carcinoma.The prevalence of HPV type 18 was found to be higher than HPV type 16 and co-infection in oral leukoplakia. It was observed that the tongue and palate lesions in the oral squamous cell carcinoma patients showed high prevalence of HPV type 16, type 18, and co-infection compared with other sites.
Source: Indian Journal of Medical Sciences - January 30, 2013 Category: Journals (General) Authors: Asok MathewRN ModyMahendra R PataitAli A RazookiNisha T VargheseKedar Saraf Source Type: research
Medtronic lets patients buy implants on EMIs; startup Mya offers medical loans
Patients can buy products such as stents, pacemakers and defibrillators priced between Rs 20,000 and Rs 5 lakh.
Source: The Economic Times Healthcare and Biotech News - January 29, 2013 Category: Pharmaceuticals Source Type: news
Time Analysis of Poly(Lactic-Co-Glycolic) Acid Nanoparticle Uptake by Major Organs Following Acute Intravenous and Oral Administration in Mice and Rats
Industrial Biotechnology , Vol. 0, No. 0.
Source: Industrial Biotechnology - January 29, 2013 Category: Biotechnology Tags: article Source Type: research
Brain Circuitry behind Cigarette Cravings Revealed
Drug cravings can be brought on by many factors, such as the sight of drugs, drug availability and lack of self-control. Now, researchers have uncovered some of the neural mechanisms involved in cigarette craving . Two brain areas, the orbitofrontal cortex and the prefrontal cortex, interact to turn cravings on or off depending on whether drugs are available, the study reports today (Jan. 28) in the journal the Proceedings of the National Academy of Sciences. [More]
Source: Scientific American - Official RSS Feed - January 29, 2013 Category: Science Tags: Health,Health,Mind & Brain,Medical Technology,Addiction Recovery,Neuroscience,Biotechnology,Biotechnology,Biology,More Science Source Type: research
Dow Jones inches toward 14,000 mark
The Dow Jones industrial average inched up today, hitting 13,958 points just after 2 p.m. The Dow hasn't hit 14,000 since October 2007. Pfizer was the Dow’s biggest gainer, up 90 cents (or 3 percent) to $27.74 a share by midafternoon Tuesday after it reported its fourth-quarter profit more than quadrupled because of a $4.8 billion gain from selling its nutrition business. Here’s a look at the top gainers today among St. Louis-based public companies, as of 2:35 p.m., according to Scott Harrison,…
Source: bizjournals.com Health Care:Biotechnology headlines - January 29, 2013 Category: Biotechnology Authors: Greta Weiderman Source Type: research
Providence, Saint John sell to Prime Healthcare Services
Prime Healthcare Services has reached an agreement to buy Providence Medical Center in Kansas City, Kan., and Saint John Hospital in Leavenworth. Terms have not yet been released, but Prime Healthcare Services has committed to maintain current acute-care and emergency department services at both campuses for at least five years, maintain current levels of charity care and provide $10 million toward capital and other investment projects during the next five years. However, according to a news release,…
Source: bizjournals.com Health Care:Biotechnology headlines - January 29, 2013 Category: Biotechnology Authors: Brianne Pfannenstiel Source Type: research
Growing tech firm Calabrio moving downtown for 'cool factor'
Software firm Calabrio Inc. is moving from Plymouth to larger digs in the North Loop neighborhood of Minneapolis as it ramps up recruiting. The company leased about 30,000 square feet inside the Wyman building at 400 1st Ave. N. Calabrio's new space will be between 6,000 and 7,000 square feet larger than its current offices. The company, which develops call-center software, has about 119 employees, and CEO Tom Goodmanson expects that number to grow to 150 by the end of the year. The North Loop's…
Source: bizjournals.com Health Care:Biotechnology headlines - January 29, 2013 Category: Biotechnology Authors: Katharine Grayson Source Type: research
Ford's Europe plans derailed + Hostess close to a Twinkie buyer + Apple releases 128GB iPad + Scientology's biggest donor now a billionaire + Monetizing the $3B Super Bowl — VIDEO
Business news from around the Web: National Ford's Europe plans derailed by stunning $2 billion loss (Forbes)Apple releases new iPad with 128 GB of storage (CNN)Scientology's biggest donor becomes a billionaire with cancer drug (Bloomberg)Microsoft to offer Office as a subscription service for $100 a year (CNN)Transportation Secretary LaHood, only Republican in Obama's cabinet, is leaving (The Business Journals)Hostess closer to a buyer for Twinkies (CNN) Chicago Chicago housing prices fall again…
Source: bizjournals.com Health Care:Biotechnology headlines - January 29, 2013 Category: Biotechnology Authors: Ed Stych Source Type: research
Teva Pharma, P&G sets up world's largest OTC plant in Gujarat
Teva Pharmaceuticals, an $18 bn generic drug maker will set up world's largest OTC medicine facility in Gujarat in collaboration with P&G.
Source: The Economic Times Healthcare and Biotech News - January 29, 2013 Category: Pharmaceuticals Source Type: news
Inslee names Brian Bonlender new state Commerce director
Washington Gov. Jay Inslee has appointed new leaders for the state Department of Commerce, Health Care Authority and Military Department. Brian Bonlender, who was Inslee’s chief of staff and primary adviser on economic issues when Inslee was a U.S. congressman, has been named director of the Commerce Department. He was the leader of Inslee’s gubernatorial transition team. “Having worked with Brian over the years, we know him to be a strong advocate for Washington State industries and a good…
Source: bizjournals.com Health Care:Biotechnology headlines - January 29, 2013 Category: Biotechnology Authors: Jennifer Sokolowsky Source Type: research
Acceleron begins Phase 2 trial of anemia treatment, earns $10M payment
Acceleron Pharma Inc. has earned a $10 million milestone payment for beginning a Phase 2 study of its drug candidate intended to treat anemia in patients with myelodysplastic syndromes (MDS), malignancies of the bone marrow that often result in low levels of blood cells. In a statement Tuesday, the 85-employee Cambridge company said that the study of ACE-536, which it’s developing in partnership with New Jersey-based Celgene Corp. (Nasdaq: CELG), will test the safety, tolerability and efficacy…
Source: bizjournals.com Health Care:Biotechnology headlines - January 29, 2013 Category: Biotechnology Authors: Don Seiffert Source Type: research